Search filters

List of works by John M Ebos

A Transient Pseudosenescent Secretome Promotes Tumor Growth after Antiangiogenic Therapy Withdrawal

scientific article published on 01 December 2018

Androgens modulate male-derived endothelial cell homeostasis using androgen receptor-dependent and receptor-independent mechanisms

scientific article published on 27 September 2016

Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond

scientific article published on 28 February 2014

Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2

scientific article

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

scientific article

Classical mathematical models for description and prediction of experimental tumor growth

scientific article (publication date: August 2014)

Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization

scientific article (publication date: 8 August 2003)

Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independent.

scientific article published on 10 March 2009

Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents.

scientific article published on October 2005

Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance

scientific article published on 01 August 2019

Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.

scientific article published on September 2004

Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment Breaks ⬇️

scientific article published on June 7, 2012

Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach

scientific article published on 28 October 2015

Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomy

scientific article published on 29 April 2014

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

scholarly article

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy

scientific article

Peering into the aftermath: The inhospitable host? ⬇️

scientific article published on October 1, 2010

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial

scientific article published on 21 December 2009

Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors

scientific article published on 25 February 2020

Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.

scientific article published on August 2013

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas

scientific article published on 13 January 2017

Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy.

scientific article published on 11 August 2009

Tumor growth fueled by spurious senescence phenotypes

scientific article published on 20 February 2019

Tumor-independent host secretomes induced by angiogenesis and immune-checkpoint inhibitors.

scientific article

Paulina is supported by:

About Paulina

Help